骨转移的患病率和风险因素以及骨转移的预后分类系统的发展:全癌症人口研究
Zhouyang Hu1,2, Sheng Yang3,4, Zhipeng Xu1,2
1Department of Pain Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, China.
Aging
|November 20, 2023
概括
骨转移 (BM) 的患病率从2010年至2019年增加了41%. 这项研究确定了风险因素,并为更好的患者治疗策略创建了一个新的分类系统.
科学领域:
- 在瘤学瘤学.
- 癌症转移研究 癌症转移研究
- 流行病学 流行病学
背景情况:
- 骨转移 (BM) 的患病率在不同类型的原发性癌症中存在显著差异.
- 肌肉瘤对患者的预后和生存结果产生重大影响.
- 关于癌BM的综合临床特征和风险因素的研究有限.
研究的目的:
- 调查胰腺癌患者骨转移相关的临床特征,患病率和风险因素.
- 为患有骨转移的患者开发预后分类系统.
- 为提供生存见解和指导骨转移的个性化治疗策略.
主要方法:
- 利用了来自监测,流行病学和最终结果 (SEER) 数据库 (2010-2019) 的数据.
- 分析了骨转移患者的患病率和预后.
- 采用等级聚类来构建预后分类系统.
主要成果:
- 2010年至2019年间,骨转移的患病率增加了41.43%.
- 上腺,肺/支气管和消化系统癌症的BM率最高.
- 确定了负面预后因素,包括年龄较大,男性性别,不良成绩,低收入和同步转移到肝脏,肺部或大脑.
- 开发了一个具有明显生存结果的三类预后系统.
结论:
- 对全癌症骨转移的临床特征,患病率和风险因素进行了全面的分析.
- 为患有骨转移的患者建立了一个新的预后分类系统.
- 该系统提供了有价值的生存信息,以帮助医生制定个性化治疗计划.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


